| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f61b14737c8a76226442661e2dcff340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0a4000b43394f4bb244d46e18968fb |
| publicationDate |
2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2647477-T3 |
| titleOfInvention |
Compositions and methods to prevent aggregation of the AAV vector |
| abstract |
A method of preventing the aggregation of AAV2 virions (adeno-associated virus type 2) in a virion preparation, comprising adding one or more excipients to AAV2 virions to produce an isotonic virion preparation with an ionic strength of at least 250 mM , wherein the AAV2 virion concentration within the preparation exceeds 1x1013 vg / ml, and wherein one or more of the excipients comprises a multivalent ion. |
| priorityDate |
2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |